BioVie Announces FDA Authorization of Investigational Bezisterim LC

There is always reason for hope, my long haul companions. People are working to help us-
https://www.biospace.com/press-releases/biovie-announces-fda-authorization-of-investigational-new-drug-application-for-phase-2-trial-to-evaluate-bezisterim-in-long-covid
Headline:

Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with long COVID

Key milestone reached ahead of schedule, with BioVie on track to receive additional $12.6 million of award from the U.S. Department of Defense and initiate the Phase 2 trial

Recent Centers for Disease Control and Prevention survey estimated over 5% of U.S. adults currently have long COVID, and ~3.6 million people reported significantly modifying their activities because of illness1